Erythromycin N-Oxide Impurity

Erythromycin N-Oxide Impurity

VS CAT No VS-E006034
CAS No NA
Mol.F. C37H65NO15
Mol.Wt. 763.9
Inv. Status Custom Synthesis

Chemical Name: (3R,4S,6R)-2-(((4R,4a'S,5S,6S,7'R,8'S,9'R,10'R,12'R,14'R,15'R,16'S,16a'S)-7'-ethyl-5,8',9',14'-tetrahydroxy-4-methoxy-4,6,8',10',12',14',16'-heptamethyl-5',11'-dioxohexadecahydro-4'H,5'H-spiro[pyran-2,2'-[1,3]dioxino[5,4-c][1]oxacyclotetradecin]-15'-yl)oxy)-3-hydroxy-N,N,6-trimethyltetrahydro-2H-pyran-4-amine oxide

Shipping Temperature: Ambient

Country of Origin: India

Erythromycin N-Oxide Impurity is chemically (3R,4S,6R)-2-(((4R,4a'S,5S,6S,7'R,8'S,9'R,10'R,12'R,14'R,15'R,16'S,16a'S)-7'-ethyl-5,8',9',14'-tetrahydroxy-4-methoxy-4,6,8',10',12',14',16'-heptamethyl-5',11'-dioxohexadecahydro-4'H,5'H-spiro[pyran-2,2'-[1,3]dioxino[5,4-c][1]oxacyclotetradecin]-15'-yl)oxy)-3-hydroxy-N,N,6-trimethyltetrahydro-2H-pyran-4-amine oxide. Erythromycin N-Oxide Impurity is supplied with detailed characterization data compliant with regulatory guideline. Erythromycin N-Oxide Impurity can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Erythromycin.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. Vsquare products are for analytical purpose only and not for human use.